3Odor J, Albert P, Carlier A, et al. In vitro and in vivo anti - tumoral effect of curcumin against melanoma cells [ J ]. Int J Cancer,2004,111 (3) :381.
4Ushida J,Sugie S, Kawabata K,et al. chemopreventive effect of curcurain on N - nitrosomethylbenzylaminc - induced esophageal carcinogenesis in rats[J]. Jpn J Cancer Res,2000,91 (9) :893.
2Jacobs EJ, Connell CJ, Rodriguez C, et al. Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst, 2004, 96:524-528.?A
3Wolff RA. Chemoprevention for pancreatic cancer. Int J Gastrointest Cancer, 2003,33:27-41.?A
4Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent,in patients with high-risk or pre-malignant lesions. Anticancer Res,2001,21:2895-2900.?A
6Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells[J]. Cancer Lett, 2001, 172(2):111-118.
7Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase Ⅰ clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions[J]. Anticancer Res, 2001, 21(4B):2895-2900.
8Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, et al. Strategy and planning for chemopreventive drug development: clinical development plansⅡ[J]. J Cell Biochem Suppl, 1996, 26:54-71.
9Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J]. Adv Enzyme Regul, 1984, 22:27-55.
10Chou TC, Motzer RJ, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism of Taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design[J]. J Natl Cancer Inst, 1994, 86(20):1517-1524.
